NasdaqCM - Nasdaq Real Time Price USD
VYNE Therapeutics Inc. (VYNE)
1.8400
-0.0200
(-1.08%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.38M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEPORE PATRICK G Director | Purchase at price 2.92 per share. | Direct | 43,800 | Jan 15, 2025 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) at price 2.96 per share. | Direct | 11,547 | Nov 29, 2024 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) at price 2.16 per share. | Direct | 9,562 | May 31, 2024 |
| HARSCH MUTYA FONTE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| STUART IAIN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| ZERONDA TYLER Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| HARSCH MUTYA FONTE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
| STUART IAIN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
| ZERONDA TYLER Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 13, 2023 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) at price 2.81 per share. | Direct | 6,426 | Nov 30, 2023 |
| LEPORE PATRICK G Director | Purchase at price 3.91 per share. | Direct | 50,778 | Nov 15, 2023 |
| HARSCH MUTYA FONTE General Counsel | Stock Award(Grant) at price 6.29 per share. | Direct | 23,047 | May 31, 2023 |
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) at price 6.29 per share. | Direct | 17,398 | May 31, 2023 |
Related Tickers
ATXI Avenue Therapeutics, Inc.
0.2580
-4.44%
ELTX Elicio Therapeutics, Inc.
5.22
+3.37%
ERNA Ernexa Therapeutics Inc.
0.1938
+5.21%
ELVN Enliven Therapeutics, Inc.
17.77
-1.11%
GLYC GlycoMimetics, Inc.
0.2387
+4.69%
NTHI NeOnc Technologies Holdings, Inc.
5.88
-2.00%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
7AY1.F Actinium Pharmaceuticals, Inc.
1.1160
-6.92%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%